Scholars Central

Conference abstract

Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus

Authors: Wafaa Emam, Ayat M Eldomouky, Ashraf S Hegab, Amal AlShahat, Nermin Raafat

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Diabetes mellitus has become the third human killer following cancer and cardiovascular disease. Millions of patients, often children, suffer from type 1 diabetes (T1D). Stem cells created hopes to regenerate damaged body tissues and restore their function. Aim: This work aimed at clarifying and comparing the therapeutic potential of differentiated and non-differentiated mesenchymal stem cells (MSCs) as a new line of therapy for T1D. Methodology: 40 female albino rats divided into Group I (control): 10 rats and group II (diabetic), III and IV, 10 rats in each, were injected with streptozotocin (50mg/kg body weight). Group III (MSCs) were transplanted with bone marrow derived MSCs from male rats and group IV (IPCs) with differentiated insulin producing cells. Blood and pancreatic tissue samples were taken from all rats for biochemical and histological studies. Results: MSCs reduced hyperglycemia in diabetic rats on day 15 while IPCs normalizes blood glucose level on day 7. Histological and morphometric analysis of pancreas of experimental diabetic rats showed improvement in MSCs-treated group but in IPCstreated group, β-cells insulin immunoreactions were obviously returned to normal, with normal distribution of β-cells in the centre and other cells at the periphery. Meanwhile, most of the pathological lesions were still detected in diabetic rats. Conclusions: MSCs transplantation can reduce blood glucose level in recipient diabetic rats. IPCs initiate endogenous pancreatic regeneration by neogenesis of islets. IPCs are better than MSCs in regeneration of β-cells. So, IPCs therapy can be considered clinically to offer a hope for patients suffering from T1D.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Gastroenterology and Hepatology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Gastroenterology and Hepatology
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Wafaa Emam”
  • BylineArticles whose byline prints “Ayat M Eldomouky”
  • BylineArticles whose byline prints “Ashraf S Hegab”
  • BylineArticles whose byline prints “Amal AlShahat”
  • BylineArticles whose byline prints “Nermin Raafat”